SSB-4

N/A

Report date: 2024/02/23 17:49:45

Base Information

Drug NameSSB-4

Drug Alias NameSSB-4

ClassificationBiologics

Mechanisms of ActionVirus internalization inhibitors

TargetsUpdating

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAB Biosciences Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

ATC CodeN/A